Low-dose buprenorphine patch for autism symptoms in children
Part of Mental health clinical trials.
This study tests whether a low-dose buprenorphine skin patch can help reduce severe autism symptoms in children and teens. It aims to see if the patch is safe and effective for managing challenging behaviors in ASD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 18 years old.
- They must have a confirmed diagnosis of autism spectrum disorder (ASD) with severe symptoms.
- They cannot have other major mental health conditions (except ADHD) or serious medical problems like heart disease, seizures, or bleeding disorders.
- They must not be allergic to buprenorphine or have breathing problems like asthma.
- A parent or guardian must agree to join all visits, give consent, and help with the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This trial tests if the drug pimavanserin can help reduce rigid or repetitive behaviors in people with autism spectrum disorder. It may be an option if you or your child struggle with these symptoms and want to try a new treatment.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.